Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Desheng Lv"'
Publikováno v:
Thoracic Cancer, Vol 11, Iss 1, Pp 55-61 (2020)
Background Previous investigations have revealed that miR‐563 is associated with a number of diseases including the ossification of posterior longitudinal ligament, Parkinson's disease or drug resistance to leukemia. Yet, the role of miR‐563 and
Externí odkaz:
https://doaj.org/article/0ec65d175b1d45248ccccfdd9c345ef8
Publikováno v:
PLoS ONE, Vol 17, Iss 2, p e0263629 (2022)
BackgroundImmunotherapy has emerged as a promising treatment for non-small cell lung cancer (NSCLC). Yet, some patients cannot benefit from immunotherapy, and reliable biomarkers for selecting sensitive patients are needed. Herein, we performed a met
Externí odkaz:
https://doaj.org/article/84b40cf102ab48e7a73c66ed72cb4502
Publikováno v:
In Journal of Surgical Research 15 May 2014 188(2):396-403
Publikováno v:
Thoracic Cancer, Vol 11, Iss 1, Pp 55-61 (2020)
Thoracic Cancer
Thoracic Cancer
Background Previous investigations have revealed that miR-563 is associated with a number of diseases including the ossification of posterior longitudinal ligament, Parkinson's disease or drug resistance to leukemia. Yet, the role of miR-563 and its
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f3a256d524f06ce4d059b554e9cd918
https://doi.org/10.1111/1759-7714.13257
https://doi.org/10.1111/1759-7714.13257
Publikováno v:
Optics Letters. 47:2073
Accurate magnetic field measurement is the key to evaluating the second-order Zeeman effect. The conventional method is to deduce the magnetic field by determining the center frequency of the magnetic-field-sensitive Ramsey fringes. In this Letter, w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::439da997b2f9a4a4e28f3524127bcea6
https://doi.org/10.1364/ol.455269
https://doi.org/10.1364/ol.455269
Publikováno v:
SCIENTIA SINICA Vitae. 48:65-72
Ouabain, a cardiac glycoside found in plants, is primarily used in the treatment of congestive heart failure and arrhythmia. Recently ouabain has been shown to exert anticancer effects, but the underlying mechanism is not clear. Aberrant activation o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::053aad62501e692db2c1f7876cee294e
https://doi.org/10.1360/n052017-00222
https://doi.org/10.1360/n052017-00222
Publikováno v:
International Journal of Oncology. 50:2079-2090
Histone deacetylases (HDACs) are crucial for regulating chromatin activity, which plays a critical role in cell proliferation, differentiation, and apoptosis of various cancers. Therefore, HDAC inhibitors have been applied as effective therapeutic ag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb7d6e4fd1b78c61a5ee85f75e0294ea
https://doi.org/10.3892/ijo.2017.3967
https://doi.org/10.3892/ijo.2017.3967
Publikováno v:
Open Medicine, Vol 13, Iss 1, Pp 278-280 (2018)
Open Medicine
Open Medicine
BRAF mutations are known as oncogenic drivers of non-small cell lung cancer (NSCLC). BRAF inhibition has demonstrated anti-tumor activity in patients with BRAF V600E mutant NSCLC. Further molecular screening for novel BRAF thr599dup mutation is warra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c14d67e1211d8789d58baf8a298f6de
https://doaj.org/article/3f591020aff84376a506ba6e3cce35aa
https://doaj.org/article/3f591020aff84376a506ba6e3cce35aa
Autor:
Hui Tian, Xuefei Zhang, Ge Sun, Zhibo Miao, Weifeng Wang, Changhong Liu, Xiaowei Dong, Desheng Lv, Ming Yao, Hui Chen, Kai Wang, Mo Li, Yanlin Li
Publikováno v:
Lung Cancer. 118:27-29
Objectives RET fusions have been reported in 1–2% of lung adenocarcinomas, and represent an actionable target. Patients whose tumors possess RET fusion are associated with clinical benefit from the treatment with multi-kinase inhibitors such as cab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e72404368194635093c1eb58823b3b25
https://doi.org/10.1016/j.lungcan.2017.08.019
https://doi.org/10.1016/j.lungcan.2017.08.019
Publikováno v:
Journal of Cancer Research & Therapeutics. 2016 Supplement 4, Vol. 12 Issue 8, pC309-C316. 8p.